Gram-Negative Bacterial Resistance.
Key Insights
- The rapid worldwide spread of antimicrobial resistance among gram-negative bacteria is driven by a complex interplay of human, environmental, and health care-associated factors and accelerated by mobile genetic elements that facilitate the dissemination of resistance genes.
- Resistance in gram-negati.
Show formatted citation
@misc{ acaciamarkets-research-gram-negative-bacterial-resistance,
title = { Gram-Negative Bacterial Resistance. },
author = { PD Tamma },
year = { 2026 },
doi = { 10.1056/NEJMra2506114 },
url = { https://pubmed.ncbi.nlm.nih.gov/42950203/ },
note = {Summarized and classified by AcaciaFund}
}
TY - GEN TI - Gram-Negative Bacterial Resistance. AU - PD Tamma PY - 2026 DO - 10.1056/NEJMra2506114 UR - https://pubmed.ncbi.nlm.nih.gov/42950203/ ER -
Edit on GitHub — registry.json
Overview
The rapid worldwide spread of antimicrobial resistance among gram-negative bacteria is driven by a complex interplay of human, environmental, and health care-associated factors and accelerated by mobile genetic elements that facilitate the dissemination of resistance genes. Resistance in gram-negative bacteria arises primarily through reduced drug entry, active drug efflux, modification of antibiotic targets, and enzymatic drug inactivation, most notably through β-lactamase production. Clinicall
Key Topics
- Market Microstructure: A theme covered by this item within the markets context.
Why It Matters
This item adds to the markets knowledge base. Practitioners can use it to stay current on Gram-Negative Bacterial Resistance, but should validate its claims against primary sources and more recent work before relying on it in production decisions.
Key Takeaways
- Understand how Gram-Negative Bacterial Resistance relates to markets workflows and controls.
- Assess evidence quality and freshness before acting on the findings.
- Use the tagged topics to connect this item to related content in the library.